Ondansetron versus a chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: a prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy.
Sykes, A J
Ondansetron versus a chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: a prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy. [electronic resource] - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Nov 1997 - 500-3 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0941-4355
10.1007/s005200050119 doi
Adult
Antiemetics--therapeutic use
Chlorpromazine--therapeutic use
Cost-Benefit Analysis
Dexamethasone--therapeutic use
Drug Therapy, Combination
Hemibody Irradiation--adverse effects
Humans
Nausea--drug therapy
Ondansetron--therapeutic use
Prospective Studies
Quality of Life
Severity of Illness Index
Vomiting--drug therapy
Ondansetron versus a chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: a prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy. [electronic resource] - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Nov 1997 - 500-3 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0941-4355
10.1007/s005200050119 doi
Adult
Antiemetics--therapeutic use
Chlorpromazine--therapeutic use
Cost-Benefit Analysis
Dexamethasone--therapeutic use
Drug Therapy, Combination
Hemibody Irradiation--adverse effects
Humans
Nausea--drug therapy
Ondansetron--therapeutic use
Prospective Studies
Quality of Life
Severity of Illness Index
Vomiting--drug therapy